Dry Eye Medication Market Report 2026

Dry Eye Medication Market Overview

• Dry Eye Medication market size has reached to $12.13 billion in 2025 • Expected to grow to $20.05 billion in 2030 at a compound annual growth rate (CAGR) of 10.7% • Growth Driver: Surge In Ocular Surgery Procedures Boosts Demand For Dry Eye Medication • Market Trend: Innovative Single-Ingredient Prescription Eye Drops Revolutionize Dry Eye Treatment • North America was the largest region in 2025 and Middle East is the fastest growing region.

What Is Covered Under Dry Eye Medication Market?

Dry eye medication refers to the drugs or medication that is used to treat dry eye by increasing your eye moisture. A multifactorial condition of the tears and ocular surface known as dry eye causes symptoms such as pain, blurred vision, and tear film instability, as well as the possibility of ocular surface injury. The main types of dry eye medication are aqueous dry eye syndrome and evaporative dry eye syndrome. Dry eye syndrome is a frequent problem that arises when the tears aren't able to keep the eyes lubricated enough. Tears may be insufficient and unstable for a variety of causes. The different types of products include liquid drops, gel, liquid wipes, and eye ointment and are used by hospital pharmacies, eye health clinics, retail pharmacies, and online pharmacies.

What Is The Dry Eye Medication Market Growth Forecast?

The dry eye medication market size is expected to see rapid growth in the next few years. It will grow to $20.05 billion in 2030 at a compound annual growth rate (CAGR) of 10.7%. The growth in the forecast period can be attributed to technological advancements in eye care, expansion of teleophthalmology, growing preference for home-based therapies, rising healthcare expenditure, introduction of multi-action eye care products. Major trends in the forecast period include increased adoption of combination eye drops, rise in otc dry eye products, development of lipid-based eye therapies, growth in prescription eye drop usage, expansion of online pharmacy distribution.

Global Dry Eye Medication Market Segmentation

1) By Type Of Product: Aqueous, Evaporative, Aqueous and Evaporative 2) By Delivery System: Liquid, Gel, Ointment, Other Delivery System 3) By Prescription Type: OTC Drugs, Prescription Drugs 4) By End-User: Hospital Pharmacies, Eye Health Clinics, Retail Pharmacies, Online Pharmacies Subsegments: 1) By Aqueous: Artificial Tears, Prescription Eye Drops, Ophthalmic Solutions 2) By Evaporative: Punctal Plugs, Lipid-Based Eye Drops, Eye Ointments 3) By Aqueous and Evaporative: Combination Eye Drops, Multi-Action Eye Care Products

What Is The Driver Of The Dry Eye Medication Market?

The rising number of ocular surgery procedures is expected to propel the growth of the dry eye medication market. Ocular surgery refers to a branch of surgery that focuses on the diagnosis, treatment, and surgical management of various eye conditions and diseases. Dry eye medication is essential in eye surgery to ensure the eye's surface remains lubricated and comfortable, facilitating smoother surgical procedures and post-operative recovery. For instance, in July 2025, according to the GOV.UK, a UK-based intergovernmental organization, In the financial year ending 2024, there were 581,369 admissions to hospital for cataract surgery in England, a rate of 5,160 (5,144 to 5,176) per 100,000 population, which was significantly higher than both the previous financial year rate of 4,679 (4,663 to 4,694). Therefore, the rising number of ocular surgery procedures is driving the growth of the dry eye medication industry.

Key Players In The Global Dry Eye Medication Market

Major companies operating in the dry eye medication market are Allergan plc, Alcon Inc., Bausch Health Companies Inc., Novartis AG, Otsuka Holdings Co. Ltd., Santen Pharmaceutical Co. Ltd., Sentiss Pharma Pvt. Ltd., OASIS Medical Inc., VISUfarma B.V., Sun Pharmaceutical Industries Limited, Bayer AG, Pfizer, Johnson & Johnson, Daiichi Sankyo, Zhaoke Ophthalmology Pharmaceutical, Implandata ophthalmic products GmbH, The Geuder Group, Novamedika, Aflofarm Farmacja Polska, VUAB Pharma Inc., Alimera Sciences, Eyegate, Neurotech, Opthotech, Eyepoint Pharmaceuticals, ReGenTree LLC, Regenerx Biopharmaceuticals Inc, Shire, Gama Vision, Biolab Pharma, Novaliq GmbH, Horus Pharma, Prestige Consumer Healthcare Inc., Azura Ophthamics Ltd, Similasan, Hoya Corporation, Adcock Ingram

Global Dry Eye Medication Market Trends and Insights

Major companies operating in the drugs for dry eye memarket are increasing their focus on introducing single-ingredient prescription eye drops such as Miebo to maximize revenue in the market. Miebo is a prescription eye drop used to treat the signs and symptoms of dry eye disease. For instance, in September 2023, Bausch + Lomb, a US-based eye health company, launched Miebo in the United States for the treatment of the signs and symptoms of dry eye disease. Miebo is the first and only prescription eye drop that directly targets tear evaporation, the leading cause of dry eye disease. Miebo is a single-ingredient prescription eye drop free from water, preservatives, and steroids that spreads quickly and comfortably, reducing tear evaporation at the ocular surface.

What Are Latest Mergers And Acquisitions In The Dry Eye Medication Market?

In September 2023, Bausch + Lomb, a US-based global eye health company, completed the acquisition of XIIDRA®, a prescription medication for the treatment of dry eye disease, from Novartis for an undisclosed amount. With this acquisition, Bausch + Lomb aims to expand its prescription ophthalmic portfolio, strengthen its position in the dry eye therapeutics market, and enhance its ability to address growing patient needs with a broader range of eye care solutions. Novartis AG, a Switzerland-based pharmaceutical company, offers dry eye medications.

Regional Insights

North America was the largest region in the market in 2025. Middle East is expected to be the fastest-growing region in the global dry eye medication market share during the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Dry Eye Medication Market?

The dry eye medication market consists of sales of polyethylene glycol, polyvinyl alcohol, propylene glycol, carboxymethylcellulose, povidone, glycerine, and mineral oil. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Dry Eye Medication Market Report 2026?

The dry eye medication market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the dry eye medication industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.